» Articles » PMID: 35770273

BA.2.12.1 is a New Omicron Offshoot That is a Highly Contagious but Not Severe Disease

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2022 Jun 30
PMID 35770273
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients with Different Variants of SARS-CoV-2 in a Tertiary Care Hospital, Thailand.

Hengkrawit K, Thananon J, Telapol K, Chiewchalermsri C Trop Med Infect Dis. 2024; 9(11).

PMID: 39591272 PMC: 11598002. DOI: 10.3390/tropicalmed9110266.


Genomic profiling and spatial SEIR modeling of COVID-19 transmission in Western New York.

Bard J, Jiang N, Emerson J, Bartz M, Lamb N, Marzullo B Front Microbiol. 2024; 15:1416580.

PMID: 39397798 PMC: 11468862. DOI: 10.3389/fmicb.2024.1416580.


Insight into genomic organization of pathogenic coronaviruses, SARS-CoV-2: Implication for emergence of new variants, laboratory diagnosis and treatment options.

Bedada F, Gorfu G, Teng S, Neita M Front Mol Med. 2024; 2:917201.

PMID: 39157715 PMC: 11328875. DOI: 10.3389/fmmed.2022.917201.


Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).

Chrysostomou A, Vrancken B, Haralambous C, Alexandrou M, Gregoriou I, Ioannides M Viruses. 2023; 15(9).

PMID: 37766339 PMC: 10535466. DOI: 10.3390/v15091933.


The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.

Xiang T, Wang J, Zheng X Virol Sin. 2022; 37(6):786-795.

PMID: 36427646 PMC: 9681989. DOI: 10.1016/j.virs.2022.11.007.

References
1.
Yamasoba D, Kosugi Y, Kimura I, Fujita S, Uriu K, Ito J . Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies. Lancet Infect Dis. 2022; 22(7):942-943. PMC: 9179126. DOI: 10.1016/S1473-3099(22)00365-6. View

2.
Wei C, Shan K, Wang W, Zhang S, Huan Q, Qian W . Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J Genet Genomics. 2021; 48(12):1111-1121. PMC: 8702434. DOI: 10.1016/j.jgg.2021.12.003. View

3.
Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L . BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022; 608(7923):593-602. PMC: 9385493. DOI: 10.1038/s41586-022-04980-y. View

4.
Rodino K, Peaper D, Kelly B, Bushman F, Marques A, Adhikari H . Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1. J Clin Microbiol. 2022; 60(6):e0060022. PMC: 9199403. DOI: 10.1128/jcm.00600-22. View

5.
Fang F, Shi P . Omicron: a drug developer's perspective. Emerg Microbes Infect. 2021; 11(1):208-211. PMC: 8741250. DOI: 10.1080/22221751.2021.2023330. View